UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer: an Updated Systematic Review

Clinical oncology (Royal College of Radiologists (Great Britain)), 2021-12, Vol.33 (12), p.e599-e612

2021

Volltextzugriff (PDF)

Stockholm3 validation in a multi-Ethnic cohort for ProsTAte cancer (SEPTA) detection: A multicentered, prospective trial

EUROPEAN UROLOGY, 2024, Vol.85, p.S1692-S1693

2024

Volltextzugriff (PDF)

SEPERA – a novel artificial intelligence-based side-specific extra-prostatic extension risk assessment tool for patients undergoing radical prostatectomy

EUROPEAN UROLOGY, 2023, Vol.83, p.S685-S686

2023

Volltextzugriff (PDF)

Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer

Prostate cancer and prostatic diseases, 2021-03, Vol.24 (1), p.69-76

2021

Volltextzugriff (PDF)

Prostate cancer detection after negative biopsy: MRI, biomarker or systematic biopsy

European urology open science (Online), 2020-07, Vol.19, p.e1739-e1740

2020

Volltextzugriff (PDF)

Development, multi-institutional external validation, and algorithmic audit of SEPERA – An artificial intelligence-based side-specific extra-prostatic extension risk assessment tool for patients undergoing radical prostatectomy

European urology open science (Online), 2023-02, Vol.48, p.S4

2023

Volltextzugriff (PDF)

A Systematic Review, Critical Appraisal And Analysis Of The Quality Of Economic Evaluations In Stroke Imaging

Value in health, 2014-05, Vol.17 (3), p.A121-A121

2014

Volltextzugriff (PDF)

Development of the Bladder Utility Symptom Scale (BUSS utility): A novel tool to measure utilities and quality of life in bladder cancer patients

European urology, 2024-03, Vol.85, p.S1187

2024

Volltextzugriff (PDF)

A0368 - Development of the Bladder Utility Symptom Scale (BUSS utility): A novel tool to measure utilities and quality of life in bladder cancer patients

European urology, 2024-03, Vol.85, p.S1187-S1187

2024

Volltextzugriff (PDF)

Risk of upper tract urothelial carcinoma recurrence following non-muscle invasive bladder cancer: A retrospective, multi-institutional analysis of 3,036 patients

European urology, 2024-03, Vol.85, p.S812

2024

Volltextzugriff (PDF)

Temporal validation of an artificial intelligence tool (SEPERA) to inform nerve-sparing strategy during radical prostatectomy and comparison against urologists

European urology, 2024-03, Vol.85, p.S675-S676

2024

Volltextzugriff (PDF)

A0100 - Risk of upper tract urothelial carcinoma recurrence following non-muscle invasive bladder cancer: A retrospective, multi-institutional analysis of 3,036 patients

European urology, 2024-03, Vol.85, p.S812-S812

2024

Volltextzugriff (PDF)

A0003 - Temporal validation of an artificial intelligence tool (SEPERA) to inform nerve-sparing strategy during radical prostatectomy and comparison against urologists

European urology, 2024-03, Vol.85, p.S675-S676

2024

Volltextzugriff (PDF)

Stockholm3 validation in a multi-ethnic cohort for prostate cancer (SEPTA) detection: A multicentered, prospective trial

Journal of clinical oncology, 2024, Vol.42 (4_suppl), p.262-262

2024

Volltextzugriff (PDF)

Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered Trial

Journal of clinical oncology, 2024-07

2024

Volltextzugriff (PDF)

Characterizing the impact of novel patient-centered pathology reports: A randomized controlled trial of patients undergoing prostate biopsy

European urology, 2024-03, Vol.85, p.S933-S934

2024

Volltextzugriff (PDF)

A0185 - Characterizing the impact of novel patient-centered pathology reports: A randomized controlled trial of patients undergoing prostate biopsy

European urology, 2024-03, Vol.85, p.S933-S934

2024

Volltextzugriff (PDF)

A0725 - Stockholm3 validation in a multi-Ethnic cohort for ProsTAte cancer (SEPTA) detection: A multicentered, prospective trial

European urology, 2024-03, Vol.85, p.S1692-S1693

2024

Volltextzugriff (PDF)

P045 - Proportion of Gleason 8-10 prostate cancer found on biopsy and tumor aggressiveness in matched cohorts of men in Asia and Western countries

European urology, 2024-03, Vol.85, p.S60-S60

2024

Volltextzugriff (PDF)

Proportion of Gleason 8-10 prostate cancer found on biopsy and tumor aggressiveness in matched cohorts of men in Asia and Western countries

European urology, 2024-03, Vol.85, p.S60

2024

Volltextzugriff (PDF)

Exploring the value of using patient-oriented mri reports in clinical practice

European urology, 2022-02, Vol.81, p.S715-S718

2022

Volltextzugriff (PDF)

A0481 - SEPERA – a novel artificial intelligence-based side-specific extra-prostatic extension risk assessment tool for patients undergoing radical prostatectomy

European urology, 2023-02, Vol.83, p.S685-S686

2023

Volltextzugriff (PDF)

Reply by Authors

The Journal of urology, 2020-11, Vol.204 (5), p.1066-1067

2020

Volltextzugriff (PDF)

Preliminary Results of a Two Stage Phase II Study of 18F-DCFPyL PET-MR for Enabling Oligometastases Ablative Therapy in Subclinical Prostate Cancer

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.E276-E276

2019

Volltextzugriff (PDF)

Treatment of Advanced Renal Cell Carcinoma: Immunotherapies Have Demonstrated Overall Survival Benefits While Targeted Therapies Have Not

European urology open science (Online), 2020-12, Vol.22, p.61-73

2020

Volltextzugriff (PDF)

1 – 25 von 239

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(208)
Mit Volltextzugriff
(185)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(134)
Life Sciences & Biomedicine
(107)
Humans
(102)
Psychiatry
(72)
Female
(65)
Male
(64)
Adult
(43)
Medicin Och Hälsovetenskap
(42)
Neurosciences
(39)
Neurosciences & Neurology
(39)
Middle Aged
(38)
Risk Factors
(33)
Mental Depression
(27)
Bipolar Disorder
(25)
Depressive Disorder, Major - Genetics
(25)
Genome-Wide Association Study
(25)
Biological And Medical Sciences
(22)
Genetic Predisposition To Disease
(22)
Medical Sciences
(22)
Aged
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer: an Updated Systematic Review

Stockholm3 validation in a multi-Ethnic cohort for ProsTAte cancer (SEPTA) detection: A multicentered, prospective trial

SEPERA – a novel artificial intelligence-based side-specific extra-prostatic extension risk assessment tool for patients undergoing radical prostatectomy

Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer

Prostate cancer detection after negative biopsy: MRI, biomarker or systematic biopsy

Development, multi-institutional external validation, and algorithmic audit of SEPERA – An artificial intelligence-based side-specific extra-prostatic extension risk assessment tool for patients undergoing radical prostatectomy

A Systematic Review, Critical Appraisal And Analysis Of The Quality Of Economic Evaluations In Stroke Imaging

Development of the Bladder Utility Symptom Scale (BUSS utility): A novel tool to measure utilities and quality of life in bladder cancer patients

A0368 - Development of the Bladder Utility Symptom Scale (BUSS utility): A novel tool to measure utilities and quality of life in bladder cancer patients

Risk of upper tract urothelial carcinoma recurrence following non-muscle invasive bladder cancer: A retrospective, multi-institutional analysis of 3,036 patients

Temporal validation of an artificial intelligence tool (SEPERA) to inform nerve-sparing strategy during radical prostatectomy and comparison against urologists

A0100 - Risk of upper tract urothelial carcinoma recurrence following non-muscle invasive bladder cancer: A retrospective, multi-institutional analysis of 3,036 patients

A0003 - Temporal validation of an artificial intelligence tool (SEPERA) to inform nerve-sparing strategy during radical prostatectomy and comparison against urologists

Stockholm3 validation in a multi-ethnic cohort for prostate cancer (SEPTA) detection: A multicentered, prospective trial

Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered Trial

Characterizing the impact of novel patient-centered pathology reports: A randomized controlled trial of patients undergoing prostate biopsy

A0185 - Characterizing the impact of novel patient-centered pathology reports: A randomized controlled trial of patients undergoing prostate biopsy

A0725 - Stockholm3 validation in a multi-Ethnic cohort for ProsTAte cancer (SEPTA) detection: A multicentered, prospective trial

P045 - Proportion of Gleason 8-10 prostate cancer found on biopsy and tumor aggressiveness in matched cohorts of men in Asia and Western countries

Proportion of Gleason 8-10 prostate cancer found on biopsy and tumor aggressiveness in matched cohorts of men in Asia and Western countries

Exploring the value of using patient-oriented mri reports in clinical practice

A0481 - SEPERA – a novel artificial intelligence-based side-specific extra-prostatic extension risk assessment tool for patients undergoing radical prostatectomy

Reply by Authors

Preliminary Results of a Two Stage Phase II Study of 18F-DCFPyL PET-MR for Enabling Oligometastases Ablative Therapy in Subclinical Prostate Cancer

Treatment of Advanced Renal Cell Carcinoma: Immunotherapies Have Demonstrated Overall Survival Benefits While Targeted Therapies Have Not

Suchergebnisse filtern